Chretien et al., 2017 - Google Patents
Natural killer defective maturation is associated with adverse clinical outcome in patients with acute myeloid leukemiaChretien et al., 2017
View HTML- Document ID
- 8458953144414992496
- Author
- Chretien A
- Fauriat C
- Orlanducci F
- Galseran C
- Rey J
- Bouvier Borg G
- Gautherot E
- Granjeaud S
- Hamel-Broza J
- Demerle C
- Ifrah N
- Lacombe C
- Cornillet-Lefebvre P
- Delaunay J
- Toubert A
- Gregori E
- Luche H
- Malissen M
- Arnoulet C
- Nunes J
- Vey N
- Olive D
- Publication year
- Publication venue
- Frontiers in immunology
External Links
Snippet
Accumulating evidence highlights natural killer (NK) cell parameters as potential prognostic factors in cancer patients, which provides a strong rationale for developing therapeutic strategies aiming at restoring NK cell. However, reaching this point warrants better …
- 230000035800 maturation 0 title abstract description 94
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chretien et al. | Natural killer defective maturation is associated with adverse clinical outcome in patients with acute myeloid leukemia | |
| Herrmann et al. | Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML | |
| Knaus et al. | Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy | |
| Takeuchi et al. | Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma | |
| Jan et al. | Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker | |
| Pang et al. | Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes | |
| Guglielmelli et al. | Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) | |
| Braga et al. | FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells | |
| Blumenschein et al. | Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer | |
| Ferraro et al. | Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes | |
| Panagiota et al. | Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti‐CD19 CAR T‐cell Treated Patients | |
| Chretien et al. | Increased NK cell maturation in patients with acute myeloid leukemia | |
| EP3717915B1 (en) | A system and method for classifying cancer patients into appropriate cancer treatment groups and compounds for treating the patient | |
| Stikvoort et al. | Combining flow and mass cytometry in the search for biomarkers in chronic graft-versus-host disease | |
| Valadez-Cosmes et al. | Identification of novel low-density neutrophil markers through unbiased high-dimensional flow cytometry screening in non-small cell lung cancer patients | |
| Hyun et al. | Immunosuppressive role of CD11b+ CD33+ HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia | |
| Matos et al. | Maturation and phenotypic heterogeneity of human CD4+ regulatory T cells from birth to adulthood and after allogeneic stem cell transplantation | |
| Erkers et al. | High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo-and autoimmunity | |
| Ajith et al. | Humanized mouse model as a novel approach in the assessment of human allogeneic responses in organ transplantation | |
| Lustfeld et al. | High proportions of CD4+ T cells among residual bone marrow T cells in childhood acute lymphoblastic leukemia are associated with favorable early responses | |
| Guinn et al. | Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics | |
| Lee et al. | The infusion of ex vivo, interleukin-15 and-21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial | |
| Jeong et al. | Tumor-infiltrating neutrophils and non-classical monocytes may be potential therapeutic targets for HER2negative gastric cancer | |
| Lin et al. | Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice | |
| Courivaud et al. | Pre-transplant thymic function predicts is associated with patient death after kidney transplantation |